Learn About Breast Cancer and Chemotherapy: Today, Dr. Bhavesh Parekh, head of medical oncology, shares crucial information about breast cancer and chemotherapy. Learn about treatment pathways and patient experiences. Follow for more expert insights and health tips! #MarengoCIMS #MarengoAsia #MCIMSCancer #BreastCancer #BreastCancerRisk #CancerAwareness #PreventCancer #ExpertInsights

Hyperbaric therapy is my recommendation for late toxicity radiation complications in any location.

The first and largest post-commercialization study of our treatment for patients with low-grade upper tract urothelial cancer (LG-UTUC) was published in Urologic Oncology: Seminars and Original Investigations. The results show 68% of patients remained recurrence-free at three years. Learn more: https://bit.ly/3WwpZCq

"Perioperative modified FOLFIRINOX was safe and effective, with a clinically meaningful improvement in survival compared with historical controls" (adjuvant gemcitabine) open-label, single-arm, phase 2 nonrandomized controlled trial for resectable PDAC Patients received 6 cycles of neoadjuvant mFOLFIRINOX before surgery and 6 cycles of adjuvant mFOLFIRINOX*. * neoadjuvant modified 5-fluorouracil, leucovorin, oxaliplatin, and irinotecan https://ja.ma/4cILtBp

Thrilled to share my review article titled "Multifunctional and stimuli-responsive liposomes in hepatocellular carcinoma diagnosis and therapy" published in Transitional Oncology. This comprehensive review explores the potential of liposomes in targeted treatment strategies for hepatocellular carcinoma. Read it here: https://lnkd.in/du6S45PV #hepatocellularcarcinoma #liposomes #cancerresearch

Hepatic Artery Infusion therapy is a viable treatment option for colorectal cancer liver metastases. Jonathan Mizrahi, MD, shares insights into adopting this therapy, patient outcomes, and its role in oncology care. Learn more about his experience here: https://bit.ly/3DvUrWo #SponsoredArticle

At an Oncology Nursing News Case-Based Roundtable event, Beth Sandy, MSN, CRNP, FAPO, from the Abramson Cancer Center at the University of Pennsylvania shared the advanced practice provider perspective on the evolving role of targeted therapies for locally advanced or metastatic EGFR-mutated NSCLC. Read here: https://ow.ly/bLS550UzAgc

Cellular therapy for GI cancers and other solid tumors was once thought to be a pipe dream, but important progress including identification of targets has been made. Great review of this emerging area

Dr. Mizrahi discusses the role of #HAItherapy in patient care and the decision to open an HAI center in this new article for OncLive: https://bit.ly/41o37br #ColorectalCancer #HepaticArteryInfusion #HAIpump

CLINICAL SIGNIFICANCE OF NRF2 AND KEAP1 EXPRESSIONS IN NON SMALL CELL LUNG CARCINOMA, Poster Presentation, 1st International Basic Oncology Congress, (02 June 2022, 04 June 2022)